We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topics
- Shortages and supply disruptions (23)
- Safety monitoring and information (11)
- Manufacturing (7)
- Compliance and enforcement (6)
- Labelling and packaging (4)
- Import and export (3)
- Scheduling (national classification system) (3)
- Committees and advisory bodies (2)
- Legislation (2)
- Advertising (1)
- Clinical trials (1)
- Fees and payments (1)
- Medicinal cannabis hub (1)
- Weight loss products (1)
Collection content
116 result(s) found, displaying 1 to 10
-
PageKey information and updates about the shortage of Creon (pancreatic extract) capsules.
-
Medicine shortage alertsSupply constraints will continue until 31 January 2027.
-
-
PageInformation and updates about the shortages of cyclophosphamide and ifosfamide injections.
-
-
PageFind out about the shortage of Pegasys (peginterferon alfa-2a) injection.
-
PageInformation about what to include in the Product Information (PI) and Consumer Medicine Information (CMI) for products included in the Black Triangle Scheme.
-
PageInformation for applicants on requesting and preparing for pre-submission meetings for medicines and biologicals.
-
GuidanceGuidance on the mandatory requirements for reporting current and anticipated reportable medicine shortages and discontinuations in Australia.
-
PageOVERALL SUPPLY IS STABLE. THE SSSI LAPSED ON 31 MARCH 2026.